Meeting
11/19/26 Hospital Authority Board: Finance Committee
Body
Metro Nashville Network
Date
November 18, 2026
Jurisdiction
State & Local
The Metro Nashville Hospital Authority Finance Committee met on November 19, 2026, and reviewed three healthcare contracts. The committee considered a two-year Northstar Anesthesia amendment beginning January 1, 2027, through December 31, 2028; the proposal maintains required 24/7 coverage while reducing one daily service point, with a stated annual cost of about $4.02 million, an increase of $263,148, and a maximum of $4.75 million. A motion and second were made, but the vote result is not clear in the transcript; a member requested confirmation that Northstar’s third-party security questionnaire was on file. The committee approved a five-year Abbott Nutrition infant-formula agreement, under which Abbott provides product at no cost and the hospital may exit with 60 days’ notice. It also approved a three-year American Red Cross blood-products and laboratory-services agreement, from December 1, 2026, through November 30, 2029; the stated amount was approximately $304,860, with a reported annual decrease of $93,580. The committee also approved the prior meeting minutes.
On finances, management reported that Metro’s $1.6 million distribution arrived November 12 and that Metro shortened the expected distribution cycle from about 90 to 60 days; remaining FY2027 distributions were scheduled for January, March, and May. October had a positive operating margin of approximately $1.2 million, with $3.1 million positive year-to-date, though results remained below budget. The committee discussed cash and accounts-payable management, revenue-cycle performance, rising accounts-receivable days, an expected analysis of uncompensated care, and progress on the FY2026 audit; management said it did not expect material weaknesses. No other procurement actions were clearly recorded.
Source
Metro Nashville Network